New York, NY -- (ReleaseWire) -- 03/11/2013 --Roche Holding AG (OTC:RHHBY) is a Swiss pharmaceuticals and diagnostics holding company.
Reuters reported that Roche Holding AG said it has clinched European approval for its breast cancer drug Perjeta.
Roche Holding AG belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions.
Find out more on RHHBY here:
http://www.monstertradingalerts.com/market-scan/?symbol=RHHBY
Hokutou Holdings International, Inc. (Pink:HKTU) announced that it will complete production of its female supplement for sexual dysfunction this month for release and sales.
The new supplement is an all-natural product intended to help the nearly 48% of American women suffering with female sexual dysfunction (FSD). Each capsule will contain a special blend of herbs best known for their aphrodisiac qualities, including Horny Goat Weed, Macuna Pruriens, Tongkat Ali, Polypodium Vulgare, Saw Palmetto, Muira Puama, Arginine, Maca, and Panax Ginseng.
Hokutou Holdings International Inc. was operated as a development stage company for the last three years.
Get the latest trend analysis reports on HKTU here:
http://www.monstertradingalerts.com/market-scan/?symbol=HKTU
About MonsterTradingAlerts.com
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure
MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.monstertradingalerts.com/disclaimer/
Contact Info:
Alexander K. Neumann
Monster Trading Alerts
info@MonsterTradingAlerts.com
347-905-5009